MENU
+Compare
VINC
Stock ticker: NASDAQ
AS OF
Apr 1 closing price
Price
$0.57
Change
+$0.04 (+7.55%)
Capitalization
1.29M

VINC Vincerx Pharma Inc Forecast, Technical & Fundamental Analysis

Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer... Show more

VINC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for VINC with price predictions
Mar 31, 2025

VINC's RSI Oscillator is sitting in oversold zone for 9 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VINC advanced for three days, in of 227 cases, the price rose further within the following month. The odds of a continued upward trend are .

VINC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 18, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VINC as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VINC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VINC entered a downward trend on March 31, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.473) is normal, around the industry mean (13.677). P/E Ratio (0.000) is within average values for comparable stocks, (64.969). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.870). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (255.565).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VINC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VINC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
VINC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

VINC is expected to report earnings to fall 19.59% to -13 cents per share on April 01

Vincerx Pharma Inc VINC Stock Earnings Reports
Q4'24
Est.
$-0.14
Q3'24
Beat
by $0.05
Q2'24
Beat
by $0.16
Q1'24
Missed
by $0.34
Q4'23
Beat
by $0.14
The last earnings report on November 12 showed earnings per share of -17 cents, beating the estimate of -21 cents. With 225.25K shares outstanding, the current market capitalization sits at 1.29M.
A.I. Advisor
published General Information

General Information

a blank check company, which was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, and reorganization

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
260 Sheridan Avenue
Phone
+1 650 800-6676
Employees
42
Web
https://www.vincerx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCU15.370.17
+1.12%
Compania Cervecerias Unidas SA
KRNT18.93-0.15
-0.79%
Kornit Digital Ltd
ASND151.43-4.43
-2.84%
Ascendis Pharma A/S
RSVR7.40-0.23
-3.01%
Reservoir Media
RENB0.50-0.04
-7.84%
Renovaro

VINC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VINC has been loosely correlated with APVO. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if VINC jumps, then APVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VINC
1D Price
Change %
VINC100%
-1.80%
APVO - VINC
33%
Loosely correlated
+3.57%
RNA - VINC
31%
Poorly correlated
-6.58%
VNDA - VINC
30%
Poorly correlated
-2.13%
IOVA - VINC
30%
Poorly correlated
-6.46%
CRIS - VINC
29%
Poorly correlated
-9.48%
More